Pyridostigmine Bromide Tablet
Product Images NDC 65841-819

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pyridostigmine Bromide (NDC 65841-819). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Pyridotabs Mfg Figure 01)

Chemical structure of pyridostigmine bromide illustrating its molecular components, including a pyridine ring with a quaternary ammonium group and a bromide ion.*

FDA Label Image

Figure (Pyridotabs Mfg Figure 02)

Label of pyridostigmine bromide tablets USP, 60 mg oral tablets, in a unit-of-use package containing 100 tablets. The label includes the brand ZyGenerics, NDC 65841-819-01, caution about moisture sensitivity, and manufacturer information for Cadila Healthcare Ltd., Baddi, India. It also lists storage instructions and dosage advisories.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.